125 related articles for article (PubMed ID: 17088231)
1. Ecstasy toxicity: a comparison to methamphetamine and traumatic brain injury.
Warren MW; Kobeissy FH; Liu MC; Hayes RL; Gold MS; Wang KK
J Addict Dis; 2006; 25(4):115-23. PubMed ID: 17088231
[TBL] [Abstract][Full Text] [Related]
2. Calpain and caspase proteolytic markers co-localize with rat cortical neurons after exposure to methamphetamine and MDMA.
Warren MW; Larner SF; Kobeissy FH; Brezing CA; Jeung JA; Hayes RL; Gold MS; Wang KK
Acta Neuropathol; 2007 Sep; 114(3):277-86. PubMed ID: 17647000
[TBL] [Abstract][Full Text] [Related]
3. Concurrent calpain and caspase-3 mediated proteolysis of alpha II-spectrin and tau in rat brain after methamphetamine exposure: a similar profile to traumatic brain injury.
Warren MW; Kobeissy FH; Liu MC; Hayes RL; Gold MS; Wang KK
Life Sci; 2005 Dec; 78(3):301-9. PubMed ID: 16125733
[TBL] [Abstract][Full Text] [Related]
4. Calpain- and caspase-mediated alphaII-spectrin and tau proteolysis in rat cerebrocortical neuronal cultures after ecstasy or methamphetamine exposure.
Warren MW; Zheng W; Kobeissy FH; Cheng Liu M; Hayes RL; Gold MS; Larner SF; Wang KK
Int J Neuropsychopharmacol; 2007 Aug; 10(4):479-89. PubMed ID: 16882358
[TBL] [Abstract][Full Text] [Related]
5. Effects of 3,4-methylenedioxymethamphetamine (MDMA) on serotonin transporter and vesicular monoamine transporter 2 protein and gene expression in rats: implications for MDMA neurotoxicity.
Biezonski DK; Meyer JS
J Neurochem; 2010 Feb; 112(4):951-62. PubMed ID: 20002520
[TBL] [Abstract][Full Text] [Related]
6. Sustained effects of ecstasy on the human brain: a prospective neuroimaging study in novel users.
de Win MM; Jager G; Booij J; Reneman L; Schilt T; Lavini C; Olabarriaga SD; den Heeten GJ; van den Brink W
Brain; 2008 Nov; 131(Pt 11):2936-45. PubMed ID: 18842607
[TBL] [Abstract][Full Text] [Related]
7. The effects of p-chloroamphetamine, methamphetamine and 3,4-methylenedioxymethamphetamine (ecstasy) on the gene expression of cytoskeletal proteins in the rat brain.
Putzke J; Spina MG; Büchler J; Kovar KA; Wolf G; Smalla KH
Addict Biol; 2007 Mar; 12(1):69-80. PubMed ID: 17407499
[TBL] [Abstract][Full Text] [Related]
8. Crystal methamphetamine smoking among regular ecstasy users in Australia: increases in use and associations with harm.
Kinner SA; Degenhardt L
Drug Alcohol Rev; 2008 May; 27(3):292-300. PubMed ID: 18368611
[TBL] [Abstract][Full Text] [Related]
9. Association of caffeine to MDMA does not increase antinociception but potentiates adverse effects of this recreational drug.
Camarasa J; Pubill D; Escubedo E
Brain Res; 2006 Sep; 1111(1):72-82. PubMed ID: 16889759
[TBL] [Abstract][Full Text] [Related]
10. Intensity dependence of auditory evoked dipole source activity in polydrug ecstasy users: evidence from an 18 months longitudinal study.
Daumann J; Till B; Fischermann T; Rezk M; Gouzoulis-Mayfrank E
J Psychopharmacol; 2006 Mar; 20(2):236-44. PubMed ID: 16510481
[TBL] [Abstract][Full Text] [Related]
11. [Neuron apoptosis induced by 3,4-methylenedioxy methamphetamine and expression of apoptosis-related factors in rat brain].
Wang X; Zhu SP; Kuang WH; Li J; Sun X; Huang MS; Sun XL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Nov; 40(6):1000-2, 1037. PubMed ID: 20067106
[TBL] [Abstract][Full Text] [Related]
12. Increased effects of 3,4-methylenedioxymethamphetamine (ecstasy) in a rat model of depression.
Jaehne EJ; Majumder I; Salem A; Irvine RJ
Addict Biol; 2011 Jan; 16(1):7-19. PubMed ID: 20192951
[TBL] [Abstract][Full Text] [Related]
13. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
Thomasius R; Zapletalova P; Petersen K; Buchert R; Andresen B; Wartberg L; Nebeling B; Schmoldt A
J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479
[TBL] [Abstract][Full Text] [Related]
14. Behavioral efficacy of posttraumatic calpain inhibition is not accompanied by reduced spectrin proteolysis, cortical lesion, or apoptosis.
Saatman KE; Zhang C; Bartus RT; McIntosh TK
J Cereb Blood Flow Metab; 2000 Jan; 20(1):66-73. PubMed ID: 10616794
[TBL] [Abstract][Full Text] [Related]
15. Neural mechanisms of working memory in ecstasy (MDMA) users who continue or discontinue ecstasy and amphetamine use: evidence from an 18-month longitudinal functional magnetic resonance imaging study.
Daumann J; Fischermann T; Heekeren K; Thron A; Gouzoulis-Mayfrank E
Biol Psychiatry; 2004 Sep; 56(5):349-55. PubMed ID: 15336517
[TBL] [Abstract][Full Text] [Related]
16. Methamphetamine and methylenedioxymethamphetamine neurotoxicity: possible mechanisms of cell destruction.
Seiden LS; Sabol KE
NIDA Res Monogr; 1996; 163():251-76. PubMed ID: 8809863
[TBL] [Abstract][Full Text] [Related]
17. [Ecstasy].
Ege PP
Ugeskr Laeger; 2000 Jul; 162(31):4161-2. PubMed ID: 10962923
[No Abstract] [Full Text] [Related]
18. 3,4-Methylenedioxymethamphetamine increases pro-interleukin-1beta production and caspase-1 protease activity in frontal cortex, but not in hypothalamus, of Dark Agouti rats: role of interleukin-1beta in neurotoxicity.
O'Shea E; Sanchez V; Orio L; Escobedo I; Green AR; Colado MI
Neuroscience; 2005; 135(4):1095-105. PubMed ID: 16165281
[TBL] [Abstract][Full Text] [Related]
19. Traumatic mechanical injury to the hippocampus in vitro causes regional caspase-3 and calpain activation that is influenced by NMDA receptor subunit composition.
DeRidder MN; Simon MJ; Siman R; Auberson YP; Raghupathi R; Meaney DF
Neurobiol Dis; 2006 Apr; 22(1):165-76. PubMed ID: 16356733
[TBL] [Abstract][Full Text] [Related]
20. MDMA, methamphetamine and their combination: possible lessons for party drug users from recent preclinical research.
Clemens KJ; McGregor IS; Hunt GE; Cornish JL
Drug Alcohol Rev; 2007 Jan; 26(1):9-15. PubMed ID: 17364831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
